Consequently the CD34+/CD133+/CD45null cells significantly increased on the day 7 even for the second generation PROMUS PREMIER stent, which we selected as a control, contrary to our previous results for the second generation DES in stable CAD patients15. The gene discussed is CD34; the disease is coronary artery disorder.